bio chat
“Diagnostic industry would
be a game changer for
healthcare sector”
The New Delhi based Oncquest Laboratories is one of the India’s
leading super specialized laboratory in molecular and clinical
diagnostics. The company was recently selected as the winner of
‘Cancer Diagnostic Testing Laboratory of the Year’ under ASSOCHAM’s
Women’s Health Excellence Awards 2017. In an exclusive interaction
with the Biovoice News, Dr Ravi Gaur, Chief Operating Officer,
Oncquest Laboratories shared his thoughts on the company’s latest
activities, overall trends in the industry and policy. Read the excerpts
below.
BY RAHUL KOUL
Please share your
feelings on the
company receiving
‘Cancer Diagnostic
Lab of the Year
Award’ recently?
It is a great
achievement for each
one of us. Getting
an award from the
Associated Chambers
of Commerce of India
(ASSOCHAM), is
always an astounding
experience. We are
rejoicing the moment
and are celebrating the
honor accredited to us.
26
BioVoiceNews | July 2017
However, this award
has entrusted us with a
sense of responsibility
to work hard more
in terms innovation
and affordability in
the field of cancer
diagnostics.
What separates
Oncquest from the
other players in
the market? How
are you making the
difference in the
cancer diagnostics?
Oncquest’s approach
is a bit different from
other providers. We
believe in providing
very high quality and
technology-driven
comprehensive
diagnostic solutions
which are validated for
the Indian population
and that too at a highly
affordable price. We
remain committed
to bring the most
advanced technologies
to India, validate
them for the Indian
environment and then
ensure its availability
to the masses at a very
affordable price.